Blood Podcast cover image

Hodgkin lymphoma outcomes in the novel agent era, genomic safe harbors for precision T cell engineering, and a transcriptomic atlas to map imatinib resistance in CML

Blood Podcast

00:00

A Single Cell Atlas Identifies Predicted Sites for Targeted Transgene Integration

The GSH-6 CAR-T cells resisted multiple tumor re-challenges, including one re-challenge 100 days after infusion. These results suggest a profile that may help avoid tonic elevated car signaling and premature exhaustion of theCAR-T cells. In contrast to the track CAR-T cell, the GSH-4 CAR-T Cells retain a normal T-cell receptor, which may help increase in vivo expansion in some cases.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app